SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-19-000033
Filing Date
2019-10-03
Accepted
2019-10-03 18:28:22
Documents
1
Period of Report
2019-08-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5245
  Complete submission text file 0001578563-19-000033.txt   6646
Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL, UNIT 325 CHARLOTTE NC 28277
Business Address
Schmidt Keith (Reporting) CIK: 0001389235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 191137094

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations